Neogenomics (NEO) Long-Term Deferred Tax (2014 - 2016)

Neogenomics has reported Long-Term Deferred Tax for 3 years, with the latest figure at $6.5 million in Q4 2016.

• For the quarter ending Q4 2016, Long-Term Deferred Tax rose 120.06% year-over-year to $6.5 million; the trailing twelve-month figure through Dec 2016 stood at $6.5 million (up 120.06% YoY), and the FY2016 full-year result was $6.5 million, up 120.06% from the prior year.
• Long-Term Deferred Tax for Q4 2016 stood at $6.5 million, up from -$32.4 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $6.5 million in Q4 2016, with the low at -$32.4 million in Q4 2015.
• Historically, Long-Term Deferred Tax has averaged -$8.5 million across 3 years, with a median of $320000.0 in 2014.
• Annual changes were most pronounced in 2015 — Long-Term Deferred Tax sank 10227.81% — and 2016, when it surged 120.06%.
• Neogenomics' Long-Term Deferred Tax stood at $320000.0 in 2014, then slumped by 10227.81% to -$32.4 million in 2015, then soared by 120.06% to $6.5 million in 2016.
• The last three Long-Term Deferred Tax figures came in at $6.5 million (Q4 2016), -$32.4 million (Q4 2015), and $320000.0 (Q4 2014), per Business Quant data.